Literature DB >> 11712937

Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus.

C G Solomon1, F B Hu, A Dunaif, J Rich-Edwards, W C Willett, D J Hunter, G A Colditz, F E Speizer, J E Manson.   

Abstract

CONTEXT: Although oligomenorrhea has been associated cross-sectionally with insulin resistance and glucose intolerance, it is not known whether oligomenorrhea is a marker for increased future risk of type 2 diabetes mellitus (DM).
OBJECTIVE: To prospectively assess risk of type 2 DM in women with a history of long or highly irregular menstrual cycles. DESIGN AND
SETTING: The Nurses' Health Study II, a prospective observational cohort study. PARTICIPANTS: A total of 101 073 women who had no prior history of DM and who reported their usual menstrual cycle pattern at age 18 to 22 years on the baseline (1989) questionnaire. MAIN OUTCOME MEASURE: Incident reports of DM, with follow-up through 1997, compared among women categorized by menstrual cycle length (5 categories).
RESULTS: During 564 333 person-years of follow-up, there were 507 cases of type 2 DM. Compared with women with a usual cycle length of 26 to 31 days (referent category) at age 18 to 22 years, the relative risk (RR) of type 2 DM among women with a menstrual cycle length that was 40 days or more or was too irregular to estimate was 2.08 (95% confidence interval [CI], 1.62-2.66), adjusting for body mass index at age 18 years and several other potential confounding variables. The RR of type 2 DM associated with long or highly irregular menstrual cycles was greater in obese women, but was also increased in nonobese women (at body mass indexes at age 18 years of <25, 25-29, and >/=30 kg/m, RRs were 1.67 [95% CI, 1.14-2.45], 1.74 [95% CI, 1.07-2.82], and 3.86 [95% CI, 2.33-6.38], respectively).
CONCLUSION: Women with long or highly irregular menstrual cycles have a significantly increased risk for developing type 2 DM that is not completely explained by obesity.

Entities:  

Mesh:

Year:  2001        PMID: 11712937     DOI: 10.1001/jama.286.19.2421

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  92 in total

1.  Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.

Authors:  Susan Sam; Richard S Legro; Paulina A Essah; Teimuraz Apridonidze; Andrea Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

2.  Sonographic Features of the Liver Among Females with Type 2 Diabetes.

Authors:  Bárbara L Riestra-Candelaria; Loida A González-Rodríguez; Wilma Rodriguez-Mojica; Luis E Vázquez-Quiñones; Juan Carlos Jorge
Journal:  J Diagn Med Sonogr       Date:  2019-03-08

3.  Polycystic ovary syndrome is a family affair.

Authors:  Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2008-05       Impact factor: 5.958

4.  Birth weight and childhood growth in daughters of women with irregular menstrual cycles.

Authors:  Erica T Wang; Piera M Cirillo; Chia-Ning Kao; Barbara A Cohn; Marcelle I Cedars
Journal:  Gynecol Endocrinol       Date:  2013-06       Impact factor: 2.260

5.  Associations between psychiatric disorders and menstrual cycle characteristics.

Authors:  Mary Lee Barron; Louise H Flick; Cynthia A Cook; Sharon M Homan; Claudia Campbell
Journal:  Arch Psychiatr Nurs       Date:  2008-10       Impact factor: 2.218

6.  Characterizing physiological and symptomatic variation in menstrual cycles using self-tracked mobile-health data.

Authors:  Kathy Li; Iñigo Urteaga; Chris H Wiggins; Anna Druet; Amanda Shea; Virginia J Vitzthum; Noémie Elhadad
Journal:  NPJ Digit Med       Date:  2020-05-26

7.  The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS.

Authors:  Meredith Brower; Kathleen Brennan; Marita Pall; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-10-03       Impact factor: 5.958

Review 8.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 9.  Metformin and gestational diabetes.

Authors:  Charles J Glueck; Naila Goldenberg; Patricia Streicher; Ping Wang
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

10.  Menses resumption after cancer treatment-induced amenorrhea occurs early or not at all.

Authors:  Melanie H Jacobson; Ann C Mertens; Jessica B Spencer; Amita K Manatunga; Penelope P Howards
Journal:  Fertil Steril       Date:  2015-12-01       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.